Several other analysts have also recently issued reports on LPNT. TheStreet upgraded LifePoint Health from a c+ rating to a b- rating in a report on Monday, March 13th. Mizuho upped their price target on LifePoint Health from $57.00 to $62.00 and gave the company a neutral rating in a research note on Monday, March 27th. Deutsche Bank AG started coverage on LifePoint Health in a research note on Tuesday, April 4th. They issued a hold rating and a $68.00 price target on the stock. Barclays PLC increased their target price on LifePoint Health from $58.00 to $60.00 and gave the stock an equal weight rating in a research note on Monday, May 1st. Finally, Morgan Stanley began coverage on LifePoint Health in a research report on Tuesday, June 6th. They issued an equal weight rating and a $65.00 price target on the stock. Three analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the company. The company currently has an average rating of Hold and a consensus price target of $66.08.
BidaskClub downgraded shares of LifePoint Health, Inc. (NASDAQ:LPNT) from a buy rating to a hold rating in a research note released on Saturday, July 8th.
LifePoint Health (NASDAQ LPNT) traded down 0.43% during mid-day trading on Friday, reaching $58.25. 558,951 shares of the company were exchanged. The company has a market capitalization of $2.35 billion, a PE ratio of 15.37 and a beta of 0.86. The stock has a 50-day moving average price of $64.73 and a 200 day moving average price of $62.97. LifePoint Health has a one year low of $50.60 and a one year high of $70.95.
LifePoint Health (NASDAQ:LPNT) last issued its earnings results on Tuesday, August 1st. The company reported $0.96 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.06. The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.64 billion. LifePoint Health had a return on equity of 7.06% and a net margin of 2.26%. The firm’s quarterly revenue was up .2% on a year-over-year basis. During the same period in the prior year, the business earned $0.69 EPS. Analysts predict that LifePoint Health will post $4.19 EPS for the current year.
In other LifePoint Health news, Chairman William F. Carpenter III sold 82,347 shares of the firm’s stock in a transaction on Thursday, June 15th. The stock was sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the completion of the transaction, the chairman now owns 504,535 shares of the company’s stock, valued at $32,365,920.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard H. Evans sold 2,000 shares of the firm’s stock in a transaction on Thursday, May 11th. The stock was sold at an average price of $62.88, for a total value of $125,760.00. Following the transaction, the director now directly owns 17,718 shares of the company’s stock, valued at approximately $1,114,107.84. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 102,000 shares of company stock valued at $6,556,824. 7.28% of the stock is currently owned by insiders.
Large investors have recently bought and sold shares of the stock. BlackRock Inc. increased its stake in LifePoint Health by 11,671.9% in the first quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock worth $245,351,000 after buying an additional 3,714,004 shares during the period. Point72 Asset Management L.P. increased its stake in LifePoint Health by 291.1% in the first quarter. Point72 Asset Management L.P. now owns 688,352 shares of the company’s stock worth $45,087,000 after buying an additional 512,352 shares during the period. LSV Asset Management increased its stake in LifePoint Health by 56.0% in the first quarter. LSV Asset Management now owns 1,087,088 shares of the company’s stock worth $71,204,000 after buying an additional 390,015 shares during the period. Victory Capital Management Inc. boosted its position in shares of LifePoint Health by 21,324.7% in the first quarter. Victory Capital Management Inc. now owns 353,936 shares of the company’s stock worth $23,182,000 after buying an additional 352,284 shares in the last quarter. Finally, Norges Bank bought a new position in shares of LifePoint Health during the fourth quarter worth approximately $19,865,000. 98.75% of the stock is owned by hedge funds and other institutional investors.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.